Neurontin Solution
Product Images NDC 0071-2012

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Neurontin (NDC 0071-2012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Neurontin 01)

A formula illustrating the calculation of creatinine clearance (CLCr), involving age, weight, serum creatinine, and a correction factor for female patients. The formula is shown as a mathematical expression with variables for age in years, weight in kilograms, and serum creatinine in mg/dL.*

FDA Label Image

Chemical Structure (Neurontin 02)

Chemical structure diagram of the active ingredient in Neurontin, showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxymethyl group (CH2CO2H).*

FDA Label Image

Figure 1 (Neurontin 03)

A line graph showing mean pain scores over an 8-week period comparing placebo and gabapentin 3600 mg/day. The x-axis represents weeks from baseline through weeks 1 to 8, and the y-axis represents mean pain scores from 0 to 10. Two phases are indicated: a 4-week dose titration period and a 4-week fixed dose period. The graph shows a decreasing pain score trend for gabapentin and a relatively stable pain score for placebo.*

FDA Label Image

Figure 2 (Neurontin 04)

A line graph showing mean pain scores over a 7-week period for Neurontin (gabapentin) at doses of 1800 mg/day and 2400 mg/day compared to placebo. The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain scores. Gabapentin groups show decreasing pain scores over time compared to placebo.*

FDA Label Image

Figure 3 (Neurontin 05)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies,' comparing placebo (PBO) versus gabapentin (GBP) at different doses across two studies. Study 1 shows 12% response for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo with 32% and 34% for GBP 1800 mg and 2400 mg respectively. Statistical significance is indicated for the GBP groups.*

FDA Label Image

Figure 4 (Neurontin 06)

A scatter plot chart comparing the percentage difference versus daily dose (mg) for Neurontin across three studies labeled as STUDY a, STUDY b, and STUDY c. The x-axis represents daily dose in milligrams ranging from 600 to 1800 mg, while the y-axis shows the difference in percentage, ranging roughly from 2% to 22%. Data points for each study are marked with distinct symbols and positioned at various dose levels showing the difference values for each study.*

FDA Label Image

Logo (Neurontin 07)

FDA Label Image

Logo (Neurontin 07a)

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

Neurontin 100 mg capsules label by Pfizer Parke-Davis Division of Pfizer Inc. The label includes storage instructions to keep at 25°C (77°F) with permitted excursions, dosage note that each capsule contains 100 mg of gabapentin, and packaging details for 100 capsules. The label also features the Pfizer logo and a barcode.*

FDA Label Image

Principal Display Panel (300 mg Capsule Bottle Label)

Neurontin (gabapentin) capsules 300 mg label from Pfizer Parke-Davis. The label indicates 100 capsules, prescription only. It includes storage instructions at 25°C with permitted excursions between 15° to 30°C and states dispensing in child-resistant containers. The label notes the product is made in India and distributed by Pfizer Parke-Davis Division of Pfizer Inc, NY.*

FDA Label Image

Principal Display Panel (300 mg Capsule Blister Pack)

Neurontin 300 mg capsules label showing active ingredient gabapentin. The label states distribution by Parke-Davis, a division of Pfizer Inc, NY, NY 10017. The label includes FDA-required details such as lot area, expiration date, and a Barcode with a NDC format number. The layout repeats multiple label units on a single sheet.*

FDA Label Image

Principal Display Panel (300 mg Capsule Blister Pack Carton)

Packaging label for Neurontin 300 mg capsules by Parke-Davis Div of Pfizer Inc. The label indicates 50 capsules per unit dose carton, marked for in-institution use only. Storage instructions and distribution details note the product is made in India and intended for Rx only use.*

FDA Label Image

Principal Display Panel (400 mg Capsule Bottle Label)

Neurontin 400 mg capsules label from Pfizer Parke-Davis Division, containing 100 capsules. The label includes dosage instructions, storage conditions at 25°C, and indicates it is for prescription use only. The active ingredient gabapentin is listed at 400 mg per capsule. The product is made in India and distributed by Pfizer Parke-Davis.*

FDA Label Image

Principal Display Panel (400 mg Capsule Blister Pack)

Neurontin 400 mg capsules label distributed by Parke-Davis Division of Pfizer Inc, NY. Each label includes the product name, strength, active ingredient gabapentin, distributor details, and a barcode. The labels are arranged in a sheet format with multiple identical labels.*

FDA Label Image

Principal Display Panel (400 mg Capsule Blister Pack Carton)

Neurontin 400 mg capsules packaging label from Parke-Davis Division of Pfizer Inc. The label shows gabapentin as the active ingredient, with a dosage of 400 mg per capsule. The packaging contains 50 capsules and is marked for in-institution use only. The label includes storage instructions and notes the capsules are made in India.*

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Neurontin 600 mg gabapentin tablets label from Pfizer Parke-Davis. The label features storage instructions, dosage information referencing the package insert, and states the product contains 100 tablets. It indicates the medication is distributed by Pfizer Parke-Davis and manufactured in India. The label includes the NDC number 0071-0513-24 and a barcode.*

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

Label for Neurontin 800 mg (gabapentin) tablets by Pfizer Parke-Davis. The label states storage instructions, dosage guidance, and that each tablet contains 800 mg of gabapentin. It indicates a quantity of 100 tablets and is marked Rx only. The product is made in India and distributed by Pfizer Parke-Davis, Division of Pfizer Inc, NY.*

FDA Label Image

Principal Display Panel (470 mL Bottle Label)

Label for Neurontin (gabapentin) oral solution with a strength of 250 mg per 5 mL. The label includes the Pfizer logo and states a bottle volume of 470 mL. It instructs storage refrigerated at 2°C to 8°C and notes the product is Rx only. Distributed by Parke-Davis Division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (470 mL Bottle Carton)

Packaging label for Neurontin oral solution 250 mg per 5 mL by Parke-Davis Division of Pfizer Inc. The label includes multiple panels indicating the active ingredient (gabapentin), volume (470 mL), and storage instructions to refrigerate at 2°C to 8°C. It states the solution contains 250 mg of gabapentin per 5 mL dose and notes the product is prescription only.*

FDA Label Image

Principal Display Panel (470 mL Bottle Label)

Neurontin 250 mg per 5 mL oral solution label from Parke-Davis Division of Pfizer Inc. The label includes the active ingredient gabapentin, volume 470 mL, and storage instructions to refrigerate at 2°C to 8°C. The label notes prescription only and contains dosage information specifying each 5 mL contains 250 mg gabapentin.*

FDA Label Image

Principal Display Panel (470 mL Bottle Carton)

Packaging label for Neurontin oral solution with a strength of 250 mg per 5 mL. The label shows the product name Neurontin (gabapentin), a liquid oral solution in a 470 mL container. The labeler is Parke-Davis Division of Pfizer Inc. Storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F) and distribution information indicating the product is made in India are included. Multiple instances of the active ingredient strength and name appear on the label.*

FDA Label Image

Neurontin 21

Neurontin (gabapentin) oral solution 250 mg per 5 mL, 470 mL bottle label. Distributed by Parke-Davis Division of Pfizer Inc. Includes storage instructions to refrigerate at 2°C to 8°C, dosage note to see prescribing information, and a caution to keep out of reach of children. NDC 0071-2012-47 is shown.*

FDA Label Image

Neurontin 22

Packaging label for Neurontin (gabapentin) oral solution 250 mg per 5 mL by Parke-Davis Div of Pfizer Inc. The label shows a 470 mL bottle size with the strength and dosage form prominently displayed. Storage instructions and distributor information are also visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.